Home › NDC Lookup › RxCUI directory › RxCUI 1192787

American house dust mite allergenic extract 5000 AU/ML / European house dust mite allergen... — RxCUI 1192787

RxNorm drug concept · Semantic clinical drug
RxCUI 1192787 Semantic clinical drug · SCD ● Current RxNorm concept 7 FDA products 17 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1192787
Official nameAmerican house dust mite allergenic extract 5000 AU/ML / European house dust mite allergenic extract 5000 AU/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asDermatophagoides farinae extract 5000 AU/ML / Dermatophagoides pteronyssinus extract 5000 AU/ML Injectable Solution
FDA products mapped7
Package NDCs mapped17
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dermatophagoides Pteronyssinus / House Dust Mite: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's an allergenic extract made from house dust mites — tiny organisms found in household dust. If you've been having allergy symptoms like sneezing, runny nose, or asthma triggere...
  • What exactly is this shot, and why has my doctor recommended it?
  • That's a fair concern, and it's important to be honest with you: yes, serious allergic reactions — including severe ones — can happen, and in rare cases fatalities have been report...
  • Is it safe? I've heard allergy shots can cause serious reactions.
📖 Read our full Dermatophagoides Pteronyssinus / House Dust Mite guide →

🕸️ Concept Web — How American house dust mite allergenic extract 5000... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept American house dust mite allergenic extract 5000 AU/ML / European house dust mite allergenic extract 5000 AU/ML Injectable Solution RxCUI 1192787

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • American house dust mite allergenic extract 1116977
    • European house dust mite allergenic extract 1116979
    • American house dust mite allergenic extract / European house dust mite allergenic extract 1116982
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • American house dust mite allergenic extract / European house dust mite allergenic extract Injectable Solution 1116981
    • American house dust mite allergenic extract / European house dust mite allergenic extract Injectable Product 1151586
    • Injectable Solution 316949
    • Injectable Product 1151126
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • American house dust mite allergenic extract 5000 AU/ML 1192785
    • European house dust mite allergenic extract 5000 AU/ML 1192786

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • American house dust mite allergenic extract 5000 AU/ML SCDC · 1192785
  • European house dust mite allergenic extract 5000 AU/ML SCDC · 1192786
  • American house dust mite allergenic extract / European house dust mite allergenic extract Injectable Solution SCDF · 1116981
  • American house dust mite allergenic extract / European house dust mite allergenic extract Injectable Product SCDG · 1151586

📦 FDA Products & Package NDCs

7 products · 17 package NDCs
17 package NDCs map to RxCUI 1192787 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
22840-0033-06 10 mL in 1 VIAL, MULTI-DOSE (22840-0033-6) Standardized Mite Dermatophagoides farinae Greer Laboratories, Inc. 1987-02-02
22840-0033-09 50 mL in 1 VIAL, MULTI-DOSE (22840-0033-9) Standardized Mite Dermatophagoides farinae Greer Laboratories, Inc. 1987-02-02
22840-0034-03 5 mL in 1 BOTTLE, DROPPER (22840-0034-3) Standardized Mite Dermatophagoides farinae Greer Laboratories, Inc. 1987-02-02
22840-0034-06 10 mL in 1 VIAL, MULTI-DOSE (22840-0034-6) Standardized Mite Dermatophagoides farinae Greer Laboratories, Inc. 1987-02-02
22840-0034-09 50 mL in 1 VIAL, MULTI-DOSE (22840-0034-9) Standardized Mite Dermatophagoides farinae Greer Laboratories, Inc. 1987-02-02
22840-0035-06 10 mL in 1 VIAL, MULTI-DOSE (22840-0035-6) Standardized Mite Dermatophagoides pteronyssinus Greer Laboratories, Inc. 1989-06-27
22840-0035-09 50 mL in 1 VIAL, MULTI-DOSE (22840-0035-9) Standardized Mite Dermatophagoides pteronyssinus Greer Laboratories, Inc. 1989-06-27
22840-0036-03 5 mL in 1 BOTTLE, DROPPER (22840-0036-3) Standardized Mite Dermatophagoides pteronyssinus Greer Laboratories, Inc. 1989-06-27
22840-0036-06 10 mL in 1 VIAL, MULTI-DOSE (22840-0036-6) Standardized Mite Dermatophagoides pteronyssinus Greer Laboratories, Inc. 1989-06-27
22840-0036-09 50 mL in 1 VIAL, MULTI-DOSE (22840-0036-9) Standardized Mite Dermatophagoides pteronyssinus Greer Laboratories, Inc. 1989-06-27
22840-0037-03 5 mL in 1 BOTTLE, DROPPER (22840-0037-3) Standardized Mite Mix Dermatophagoides farinae and Dermatophagoides pteronyssinus Greer Laboratories, Inc. 2010-02-03
22840-0037-06 10 mL in 1 VIAL, MULTI-DOSE (22840-0037-6) Standardized Mite Mix Dermatophagoides farinae and Dermatophagoides pteronyssinus Greer Laboratories, Inc. 2010-02-03
22840-0037-09 50 mL in 1 VIAL, MULTI-DOSE (22840-0037-9) Standardized Mite Mix Dermatophagoides farinae and Dermatophagoides pteronyssinus Greer Laboratories, Inc. 2010-02-03
22840-0038-06 10 mL in 1 VIAL, MULTI-DOSE (22840-0038-6) Standardized Mite Dermatophagoides farinae Greer Laboratories, Inc. 2010-02-03
22840-0038-09 50 mL in 1 VIAL, MULTI-DOSE (22840-0038-9) Standardized Mite Dermatophagoides farinae Greer Laboratories, Inc. 2010-02-03
22840-0039-06 10 mL in 1 VIAL, MULTI-DOSE (22840-0039-6) Standardized Mite Dermatophagoides pteronyssinus Greer Laboratories, Inc. 2010-02-03
22840-0039-09 50 mL in 1 VIAL, MULTI-DOSE (22840-0039-9) Standardized Mite Dermatophagoides pteronyssinus Greer Laboratories, Inc. 2010-02-03
Observed labelers: Greer Laboratories, Inc. (17) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.